A. A. Roger Thompson

10.1k citations

67 papers · 2.2k indexed · 1 hit paper · h-index 24

Pulmonary and Respiratory Medicine top 5%
Immunology top 5%
Molecular Biology
Cancer Research top 5%
Genetics top 5%

Co-authors: Allan Lawrie Sarah R. Walmsley J. Kenneth Baillie Andrea Casazza Giusy Di Conza Massimiliano Mazzone Jens Serneels Zvi Granot
Topics: Pulmonary Hypertension Research and Treatments (31 papers)High Altitude and Hypoxia (17 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers)
Cited by: Immunology Cancer Research Endocrine and Autonomic Systems
Journals: Nature Circulation Journal of Clinical Investigation
Partner nations: United Kingdom United States Singapore

In The Last Decade

A. A. Roger Thompson

60 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MET is required for the recruitment of anti-tumoural neutrophils

2015 378 citations A. A. Roger Thompson, Sarah R. Walmsley et al. profile →

Peers

Countries citing papers authored by A. A. Roger Thompson

Since Specialization

Citations

This map shows the geographic impact of A. A. Roger Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Roger Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Roger Thompson more than expected).

Fields of papers citing papers by A. A. Roger Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. A. Roger Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Roger Thompson. The network helps show where A. A. Roger Thompson may publish in the future.

Co-authorship network of co-authors of A. A. Roger Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Roger Thompson. A scholar is included among the top collaborators of A. A. Roger Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Roger Thompson. A. A. Roger Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome 2025 ·American Journal of Respiratory and Critical Care Medicine ·Athénaïs Boucly,Shanshan Song,(unknown),Dennis Wang,Luke Howard,Marc Humbert,Olivier Sitbon,Allan Lawrie,A. A. Roger Thompson,Philipp Frank,Mika Kivimäki,Christopher J. Rhodes,Martin R. Wilkins	1
2	Diagnostic MicroRNA Signatures to Support Classification of Pulmonary Hypertension 2025 ·Circulation Genomic and Precision Medicine ·(unknown),(unknown),(unknown),Christopher J. Rhodes,(unknown),Lihan Zhou,(unknown),Eileen M. Harder,Aaron B. Waxman,T. Jatkoe,John Wharton,A. A. Roger Thompson,Robin Condliffe,David G. Kiely,Luke Howard,Mark Toshner,Cheng He,Dennis Wang,Martin R. Wilkins,Allan Lawrie	1
3	Mendelian Randomization Study With Clinical Follow‐Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension 2024 ·Journal of the American Heart Association ·(unknown),Thomas Julian,(unknown),A. A. Roger Thompson,Christopher J. Rhodes,Stefan Gräf,(unknown),Martin R. Wilkins,Allan Lawrie,Dennis Wang,Johnathan Cooper‐Knock	6
4	The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry 2024 ·The Journal of Heart and Lung Transplantation ·(unknown),A. A. Roger Thompson,Mohammed Akil,Samer Alabed,Athanasios Charalampopoulos,Krit Dwivedi,Charlie Elliot,Abdul Hameed,(unknown),(unknown),Catherine Hill,Judith Hurdman,(unknown),(unknown),Smitha Rajaram,Alexander Rothman,Andrew J. Swift,Jim M. Wild,David G. Kiely,Robin Condliffe	2
5	Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT 2024 ·Radiology ·Krit Dwivedi,Michael Sharkey,(unknown),Samer Alabed,Smitha Rajaram,Catherine Hill,Christopher Johns,Alexander Rothman,Michail Mamalakis,A. A. Roger Thompson,Jim M. Wild,Robin Condliffe,David G. Kiely,Andrew J. Swift	12
6	Mapping the amplitude and phase of dissolved ¹²⁹Xe red blood cell signal oscillations with keyhole spectroscopic lung imaging 2024 ·Magnetic Resonance in Medicine ·(unknown),Guilhem Collier,M. Takigawa,(unknown),A. A. Roger Thompson,Graham Norquay,Neil J. Stewart,Jim M. Wild	2
7	A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3 2023 ·iScience ·(unknown),Mehboob Ali,(unknown),Mingjun Liu,(unknown),Neil J. Kelly,Srimathi Bogamuwa,Hu Yang,J.D. Londino,Joseph S. Bednash,Daniela Farkas,Rama K. Mallampalli,Mark R. Nicolls,John Ryan,A. A. Roger Thompson,Stephen Y. Chan,Delphine Gomez,Elena A. Goncharova,László Farkas	11
8	Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devices 2023 ·npj Digital Medicine ·Varsha Gupta,(unknown),(unknown),(unknown),(unknown),Emmanuel Jammeh,(unknown),Naomi Meardon,Paul Collini,Joby Cole,Jim M. Wild,Steven G. Hershman,(unknown),A. A. Roger Thompson,Thushan I. de Silva,Euan A. Ashley,Dennis Wang,Allan Lawrie	4
9	S40 ERUPT: evaluation of real-world use of pulmonary embolism (PE) thrombolysis 2023 ·(unknown),A. A. Roger Thompson,(unknown),Akhilesh Jha,(unknown),Anthony De Soyza	0
10	Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography 2022 ·ERJ Open Research ·(unknown),Yousef Shahin,Faisal Alandejani,Krit Dwivedi,Samer Alabed,Christopher Johns,Allan Lawrie,A. A. Roger Thompson,Alexander Rothman,Juerg Tschirren,Johanna Uthoff,Eric A. Hoffman,Robin Condliffe,Jim M. Wild,David G. Kiely,Andrew J. Swift	19
11	Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction 2021 ·International journal of cardiac imaging ·Pankaj Garg,Robert A. Lewis,Christopher Johns,Andrew J. Swift,David Capener,Smitha Rajaram,A. A. Roger Thompson,Robin Condliffe,Charlie Elliot,Athanasios Charalampopoulos,Abdul Hameed,Alexander Rothman,Jim M. Wild,David G. Kiely	15
12	RNA Signaling in Pulmonary Arterial Hypertension—A Double-Stranded Sword 2020 ·International Journal of Molecular Sciences ·H. Turton,A. A. Roger Thompson,(unknown)	10
13	Thromboelastometry and Platelet Function during Acclimatization to High Altitude 2018 ·Thrombosis and Haemostasis ·(unknown),(unknown),Matthew Barber,Alexander Jackson,(unknown),(unknown),(unknown),J. Kenneth Baillie,(unknown),(unknown),Paul Harrison,Alastair F. Nimmo,A. A. Roger Thompson	34
14	Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension 2018 ·American Journal of Respiratory and Critical Care Medicine ·Daniela Farkas,A. A. Roger Thompson,(unknown),(unknown),Hyun Ji,(unknown),(unknown),Nadine Arnold,Adam Braithwaite,Helen Casbolt,Jennifer E. Cole,Ian Sabroe,Claudia Monaco,Carlyne D. Cool,Elena A. Goncharova,Allan Lawrie,László Farkas	50
15	Selective improvement of pulmonary arterial hypertension with a dual ET_A/ET_Breceptors antagonist in the apolipoprotein E^−/−model of PAH and atherosclerosis 2017 ·Pulmonary Circulation ·Lewis Renshall,Nadine Arnold,Laura West,Adam Braithwaite,Josephine Pickworth,Rachel Walker,Mabruka Alfaidi,Janet Chamberlain,Helen Casbolt,A. A. Roger Thompson,Cathy M. Holt,Marc Iglarz,Sheila Francis,Allan Lawrie	9
16	Retinal Vessel Tortuosity in Response to Hypobaric Hypoxia 2012 ·High Altitude Medicine & Biology ·Ian J. C. MacCormick,John Somner,Daniel S. Morris,Tom MacGillivray,Rupert Bourne,Susan S. Huang,(unknown),Peter Aspinall,J. Kenneth Baillie,A. A. Roger Thompson,Bal Dhillon	15
17	Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice 2011 ·Journal of Clinical Investigation ·Sarah R. Walmsley,Edwin R. Chilvers,A. A. Roger Thompson,(unknown),Helen M. Marriott,Lisa C. Parker,Gary S. Shaw,(unknown),Martin Schneider,Ian Sabroe,David H. Dockrell,Marta Milo,Cormac T. Taylor,Randall S. Johnson,Christopher W. Pugh,Peter J. Ratcliffe,Patrick H. Maxwell,Peter Carmeliet,Moira K. B. Whyte	132
18	Sildenafil Citrate for the Prevention of High Altitude Hypoxic Pulmonary Hypertension: Double Blind, Randomized, Placebo-Controlled Trial 2011 ·High Altitude Medicine & Biology ·Matthew G.D. Bates,A. A. Roger Thompson,J. Kenneth Baillie,Andrew Sutherland,John B. Irving,Nikhil Hirani,David J. Webb	30
19	Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro 2010 ·High Altitude Medicine & Biology ·(unknown),James Varley,(unknown),Katherine Josephs,(unknown),(unknown),Marina Njelekela,Gordon B. Drummond,Andrew Sutherland,A. A. Roger Thompson,J. Kenneth Baillie	46
20	Endothelial Nitric Oxide Synthase Polymorphisms Do Not Influence Pulmonary Artery Systolic Pressure at Altitude 2006 ·High Altitude Medicine & Biology ·Eve Smith,J. Kenneth Baillie,A. A. Roger Thompson,John B. Irving,David J. Porteous,David J. Webb	17

About A. A. Roger Thompson

A. A. Roger Thompson is a scholar working on Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Internal Medicine, having authored 67 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (31 papers), High Altitude and Hypoxia (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). The work is most often cited by research in Immunology (632 citations), Cancer Research (396 citations) and Endocrine and Autonomic Systems (160 citations). A. A. Roger Thompson has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Allan Lawrie, Sarah R. Walmsley, J. Kenneth Baillie, Andrea Casazza, Giusy Di Conza, Massimiliano Mazzone, Jens Serneels, Zvi Granot, Mario Di Matteo and Sandra Costa. Their work appears in journals such as Nature, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact